+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

7 th EULAR Course on Synovial Biopsy

European Alliance for Associations of Rheumatology

This is an integrated, one-and-a-half-day course focused on synovium biopsy. The course will be based on the format of a half day interactive lectures and a full day practical biopsy session on cadavers.

This course consists of complementary teaching units, aiming at engaging different specialists such as sonographers, clinical rheumatologists, pathologists, and translational scientists. Lectures will include a summary of recent advances in the field of synovial tissue research and detailed description with videos and teaching material of the biopsy techniques not only of large joints but also of the wrist, MCPs and MTPs. The most adequate procedures to prepare synovial samples for several types of analysis, including single cell studies, will be addressed. A practical hands-on module will then take place in the superb anatomy facility of Barcelona, where participants will have the opportunity to practice US-guided synovial needle and forceps biopsy under guidance of world recognised faculty.

Learning Objectives

• Different procedures for synovial biopsy.

• Value of synovial tissue in translational research and clinical practice.

• Utility and interpretation of the information provided by synovial tissue.

• Synovial biopsy practice in small and large joints (wrist and knee).

Official Language English.

Maximum Participants 30.

Certification

Upon successful completion of the course, all participants will receive a certificate of attendance via their EULAR School user account.

Please note that full attendance (100%) is required to receive the certificate.

CME Accreditation

EULAR will apply for EACCME accreditation for this course

COURSE PACKAGE

500 € (VAT included), package includes:

Friday, 2 October 2026

• Full access to the course.

• Coffee break.

• Engagement dinner.

Saturday, 3 October 2026

• Full access to the course.

• Coffee break.

• Lunch.

Target Audience

This is an educational activity targeting clinicians and scientists working in the field of rheumatology or musculoskeletal diseases. For this course to be the most beneficial to participants, a minimum experience in musculoskeletal ultrasound (MSUS), defined as regularly performing MSUS in current practice, as well as in US guided procedures, is mandatory. As part of the application process, you will be asked to detail your experience in both MSUS and US guided MS procedures.

AI Based Application Success Predictor

🦴 1. Strong Focus on Rheumatic & Musculoskeletal Diseases (Non-Negotiable)

Projects must directly address:
- Rheumatic and musculoskeletal diseases (RMDs)
Includes:
- Rheumatoid arthritis
- Lupus
- Spondyloarthritis
- Osteoarthritis

👉 Weak disease relevance → low success probability

🎯 2. Clear Patient-Centered Impact (Top Predictor)

EULAR strongly emphasizes:

Improving:
- Patient outcomes and quality of life
Includes:
- Symptom control
- Functional outcomes
- Long-term disease management

👉 Key evaluation question:
“Will this benefit patients living with RMDs?”

🔄 3. Translational & Clinical Relevance (Critical)

Preference for:
- Bench → bedside → real-world application
Includes:
- Clinical studies
- Implementation research
- Outcome-based research

👉 Pure basic science is less competitive unless clinically linked

👩‍🔬 4. Early-Career Researcher Development (Major Priority)

Many EULAR programs target:
- Young investigators, fellows, and clinicians

Evaluation includes:

Career trajectory
Potential for independence

👉 Strong advantage for early-career applicants

🧪 5. Feasible, Well-Designed Study

Must include:
- Clear aims
- Methodology
- Timeline

👉 Realistic scope is essential

🤝 6. Multidisciplinary & Collaborative Approach

EULAR uniquely values:
- Collaboration between:
  - Rheumatologists
  - Allied health professionals
  - Patients

👉 Team-based and patient-inclusive research is highly favored

🌍 7. European Collaboration & Mobility

Preference for:
- Cross-country training/research
Encourages:
- Knowledge exchange across Europe

👉 Mobility is a key factor in fellowships

🧠 8. Inclusion of Patient Perspective (Distinctive Predictor)

EULAR strongly promotes:
- Patient involvement in research design and outcomes

👉 Proposals including patient-reported outcomes or engagement score higher

🧬 9. Innovation in Precision Medicine & Outcomes

High success rates in:

Biomarkers
Personalized medicine
Digital health
Real-world data

👉 Innovation must be clinically meaningful

💰 10. Clear Training & Career Benefit

For fellowships:

Applicants must show:
- Skills to be gained
- Career advancement plan

👉 Training value is a major evaluation component

📊 Summary: Key Predictors (Ranked)

Highest impact factors:

RMD-specific focus
Patient-centered impact
Translational/clinical relevance

Moderate predictors:
4. Early-career development
5. Feasibility
6. Collaboration

Supporting factors:
7. Patient involvement
8. Innovation
9. Training benefit

💡 Insider Insight

Compared to other rheumatology funders:

European Alliance of Associations for Rheumatology is:
👉 highly patient-centered
👉 clinically and implementation-focused

👉 Key evaluation question:
“Will this research improve the lives of people with rheumatic diseases while developing the next generation of researchers?”

Specialties

Rheumatology

Eligibility Requirements

This is an educational activity targeting clinicians and scientists working in the field of rheumatology or musculoskeletal diseases.

Sponsor Details

Sponsor Institute/Organizations: European Alliance for Associations of Rheumatology

Sponsor Type: Corporate/Non-Profit

Address: EULAR Office Seestrasse 240, CH-8802 Kilchberg

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity